ClinicalTrials.gg
RecruitingNCT06038305Updated Nov 1, 2024

Prevalence of Anemia and Growth Assessment in Acute Gastroenteritis

An observational study in Acute Gastroenteritis, sponsored by Assiut University. Recruiting at 1 site in Egypt. Open to participants aged 1 Month to 2 Years. Per ClinicalTrials.gov, last updated 2024-11-01.

Sponsored by Assiut University · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Started Jan 2024; still recruiting 2 years 10 months later.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
297
Ages
1 Month to 2 Years
Sex
All
01

Study summary

  1. Assessment of the growth parameters in infants admitted with acute gastroenteritis.
  2. Determine the prevalence of anemia in infants admitted with acute gastroenteritis.
Read the detailed description

Gastroenteritis is inflammation of the stomach, small intestine, or large intestine, leading to a combination of abdominal pain, cramping, nausea, vomiting, and diarrhea. Acute gastroenteritis usually lasts fewer than 14 days. Worldwide, gastroenteritis affects 3 to 5 billion children each year. Up to 40% of children aged less than 5 years with diarrhea are hospitalized with rotavirus. Also, some microorganisms have been found predominantly in resource-constrained nations, including Shigella spp, Vibrio cholerae, and the protozoan infections. Malnutrition, immunosuppression, young age, and an increase in the preceding diarrhea burdens are risk factors for the development of persistent diarrhea. A substantial proportion of global malnutrition is due to impaired intestinal absorptive function resulting from multiple and repeated enteric infections. These include recurrent acute infections as well as persistent infections, even those without overt liquid diarrhea.

Child growth is internationally recognized as the best global indicator of physical well-being in children because poor feeding practices-both in quantity and quality-and infections, or more often a combination of the two, are major factors that affect physical growth and mental development in children. The most important measurements needed for growth assessment are recumbent length or height, weight and head circumference. These fundamental anthropometric measures should be obtained and interpreted at each well child visit, and are typically sufficient for growth assessment.

In this study, the prevalence of anemia and growth of infants admitted with acute gastroenteritis at Assiut University Children Hospital will be assessed. Anemia is a global public health problem, with important consequences for human health and the social and economic development of each nation. It results from single or multiple causes that act simultaneously, influencing children's health, their cognitive and physical development, and immunity, increasing the risk of infections and infant mortality.

02

Conditions studied

  • Acute Gastroenteritis

Browse trials for

03

In context

Gastroenteritis

237 studies on the registry are indexed under Gastroenteritis; 16 are open to participants now.

This study's planned enrollment of 297 is below the median of 606 across 62 observational studies indexed under Gastroenteritis.

Browse Gastroenteritis studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Month to 2 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

infants aged 1 month up to 2 years with acute gastroenteritis

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Infants with acute gastroenteritis.
  • Infants aged from 1 month and up to 2 years.

Exclusion criteria

Exclusion Criteria:

  • Infants aged less than 1 month and more than 2 years.
  • Infants with persistent and chronic diarrhea.
  • Infants with acute gastroenteritis in association with chronic disease
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
297 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Determine association between anemia and acute gastroenteritis in infants and children.

    assess anemia in children with acute gastroenteritis and if anemia affect severity of acute gastroenteritis

    Time frame: baseline

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06038305
Lead sponsor
Assiut University
Responsible party
Gehad Ali Sayed (Resident physician, Family Medicine department, Assiut University) — Principal investigator
First posted
Sep 14, 2023
Start date
Jan 1, 2024
Primary completion
Jan 2025 (estimated)
Completion
Feb 2025 (estimated)
Last update
Nov 1, 2024

Study contacts

Dalia G Mahran
Contact
Daliaym2001@yahoo.com
+201007120821 ext. Professor

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion